Thu, Apr 24, 2014, 5:00 AM EDT - U.S. Markets open in 4 hrs 30 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • networthdev networthdev Dec 19, 2012 7:20 PM Flag

    Amgen validation, they NEED more IMGN

    Yes!!!! "In the short term, the market is a voting machine, BUT, in the long term, it is a weighing machine", Warren Buffet.

    IMGN continues to prove it WILL tip the scales to the LONGS.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "On Wednesday, ImmunoGen (NASDAQ:IMGN) reported that Amgen (NASDAQ:AMGN) has licensed the exclusive right to use its maytansinoid TAP tech for the development of anticancer therapeutics to a third target whose identity is undivulged. In 2009, Amgen licensed rights for two other targets and has two compounds in clinical testing under those licenses. ImmunoGen is a biotechnology firm that develops anticancer therapeutics using its Targeted Antibody Payload tech and antibody expertise."

 
IMGN
13.90-0.66(-4.53%)Apr 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.